PrognomiQ
PrognomiQ is a biotechnology firm that develops test products for the early detection and treatment of cancer and other complex diseases through the power of multi-omics data.
Last updated on
About PrognomiQ
Founded
2020Employees
51-250Funding / Mkt. Cap
$101MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
BiotechnologyLocation
City
San MateoState
CaliforniaCountry
United StatesTech Stack (70)
